<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02336529</url>
  </required_header>
  <id_info>
    <org_study_id>H-3-2013-172</org_study_id>
    <nct_id>NCT02336529</nct_id>
  </id_info>
  <brief_title>Nerveblocks for Persistent Pain After Breast Cancer Surgery</brief_title>
  <official_title>Tenderpoint and Ultrasound Guided Nerveblocks for Persistent Pain After Breast Cancer Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kenneth Geving Andersen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Persistent pain after breast cancer surgery (PPBCS) affects 25-60% of breast cancer survivors
      and nerve damage has been implicated as the cause of this neuropathic pain condition. Local
      anaesthetic blockade of tenderpoints and the intercostobrachial nerve (ICBN) could provide
      clues to pathophysiological mechanisms as well as aiding diagnosis and treatment of PPBCS but
      has never been attempted. The aims of this study is to examine clinical effect of ultrasound
      guided blockades of the ICBN and tenderpoints of pain.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Summed pain intensity</measure>
    <time_frame>At least 1 year after surgery</time_frame>
    <description>The summed pain intensity (of pain at rest (0-10), pain during movement (0-10) and pressure pain (at 100kPa in point of maximum pain) (0-10)) 0-30</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain at rest, pain during movement and pressure pain</measure>
    <time_frame>At least 1 year after surgery</time_frame>
    <description>Pain intensity of pain at rest (0-10), pain during movement (0-10) and pressure pain (at 100kPa in point of maximum pain) (0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain related reduction of physical function</measure>
    <time_frame>At least 1 year after surgery</time_frame>
    <description>Reduction of physical function</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Pain</condition>
  <condition>Neuropathic Pain</condition>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>ICBN, active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound guided injection of bupivacain, 10mL, 0.5% in proximity of the ICBN</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICBN, placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Ultrasound guided injection of NaCl, 10mL in proximity of the ICBN</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tenderpoint, active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound guided injection of bupivacain, 20mL, 0.25% in the tenderpoint</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tenderpoint, placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Ultrasound guided injection of NaCl, 20mL in the tenderpoint</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <arm_group_label>ICBN, active</arm_group_label>
    <arm_group_label>Tenderpoint, active</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NaCl</intervention_name>
    <arm_group_label>ICBN, placebo</arm_group_label>
    <arm_group_label>Tenderpoint, placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 1 year after surgery for breast cancer

          -  Women aged 18 or over

          -  Suffering from persistent pain in the breast, side of chest, axilla or arm (NRS 4 or
             over)

        Exclusion Criteria:

          -  Previous cosmetic surgery

          -  bilateral cancer

          -  pregnant or lactating

          -  other disease in the nervous system

          -  in treatment for psychiatric disease

          -  unable to understand Danish

          -  unable to give informed concent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nelun Wijayasinghe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, University of Copenhagen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenneth G Andersen, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Rigshospitalet, University of Copenhagen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nelun Wijayasinghe, MD</last_name>
    <phone>+4535454496</phone>
    <email>nelun.wijayasinghe@regionh.dk</email>
  </overall_contact>
  <reference>
    <citation>Wijayasinghe N, Andersen KG, Kehlet H. Neural blockade for persistent pain after breast cancer surgery. Reg Anesth Pain Med. 2014 Jul-Aug;39(4):272-8. doi: 10.1097/AAP.0000000000000101. Review.</citation>
    <PMID>24918332</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2015</study_first_submitted>
  <study_first_submitted_qc>January 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2015</study_first_posted>
  <last_update_submitted>October 26, 2015</last_update_submitted>
  <last_update_submitted_qc>October 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Kenneth Geving Andersen</investigator_full_name>
    <investigator_title>Research fellow</investigator_title>
  </responsible_party>
  <keyword>postoperative</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

